يعرض 1 - 7 نتائج من 7 نتيجة بحث عن '"Salmon, Jean-Hugues"', وقت الاستعلام: 1.08s تنقيح النتائج
  1. 1
    دورية أكاديمية
    The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis

    المؤلفون: Alten, Rieke, Burmester, Gerd, R, Matucci-Cerinic, Marco, Salmon, Jean-Hugues, Lopez-Romero, Pedro, Fakhouri, Walid, de la Torre, Inmaculada, Zaremba-Pechmann, Liliana, Holzkämper, Thorsten, Fautrel, Bruno

    المساهمون: Charité - UniversitätsMedizin = Charité - University Hospital Berlin, Università degli Studi di Firenze = University of Florence = Université de Florence (UniFI), Service de Rhumatologie Reims, Hôpital universitaire Robert Debré Reims (CHU Reims), Vieillissement, Fragilité (VIEFRA - EA 3797), Université de Reims Champagne-Ardenne (URCA), Department of Cardiovascular Epidemiology and Population Genetics, CNIC, Eli Lilly & Company, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Sorbonne Université (SU)

    المصدر: ISSN: 2198-6576.

    مصطلحات موضوعية: Rheumatoid arthritis, Baricitinib, bDMARDs, tsDMARDs, Treatment discontinuation observational study, Effectiveness, Patient-reported outcomes, [SDV]Life Sciences [q-bio]

    العلاقة: hal-03986538; https://hal.science/hal-03986538Test; https://hal.science/hal-03986538/documentTest; https://hal.science/hal-03986538/file/2787.pdfTest

    الإتاحة: https://doi.org/10.1007/s40744-022-00500-6Test
    https://hal.science/hal-03986538Test
    https://hal.science/hal-03986538/documentTest
    https://hal.science/hal-03986538/file/2787.pdfTest

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis

    المؤلفون: Alten, Rieke, Burmester, Gerd, R, Matucci-Cerinic, Marco, Salmon, Jean-Hugues, Lopez-Romero, Pedro, Fakhouri, Walid, de la Torre, Inmaculada, Zaremba-Pechmann, Liliana, Holzkämper, Thorsten, Fautrel, Bruno

    المساهمون: Charité - UniversitätsMedizin = Charité - University Hospital Berlin, Università degli Studi di Firenze = University of Florence = Université de Florence (UniFI), Service de Rhumatologie Reims, Hôpital universitaire Robert Debré Reims (CHU Reims), Vieillissement, Fragilité (VIEFRA - EA 3797), Université de Reims Champagne-Ardenne (URCA), Department of Cardiovascular Epidemiology and Population Genetics, CNIC, Eli Lilly & Company, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Sorbonne Université (SU)

    المصدر: ISSN: 2198-6576.

    مصطلحات موضوعية: Rheumatoid arthritis, Baricitinib, bDMARDs, tsDMARDs, Treatment discontinuation observational study, Effectiveness, Patient-reported outcomes, [SDV]Life Sciences [q-bio]

    العلاقة: hal-03986538; https://hal.science/hal-03986538Test; https://hal.science/hal-03986538/documentTest; https://hal.science/hal-03986538/file/2787.pdfTest

    الإتاحة: https://doi.org/10.1007/s40744-022-00500-6Test
    https://hal.science/hal-03986538Test
    https://hal.science/hal-03986538/documentTest
    https://hal.science/hal-03986538/file/2787.pdfTest

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    The RA-BE-REAL Multinational, Prospective, Observational Study in Patients with Rheumatoid Arthritis Receiving Baricitinib, Targeted Synthetic, or Biologic Disease-Modifying Therapies: a 6-Month Interim Analysis

    المؤلفون: Alten, Rieke, Burmester, Gerd, R, Matucci-Cerinic, Marco, Salmon, Jean-Hugues, Lopez-Romero, Pedro, Fakhouri, Walid, de la Torre, Inmaculada, Zaremba-Pechmann, Liliana, Holzkämper, Thorsten, Fautrel, Bruno

    المساهمون: Charité - UniversitätsMedizin = Charité - University Hospital Berlin, Università degli Studi di Firenze = University of Florence (UniFI), Service de Rhumatologie Reims, Hôpital universitaire Robert Debré Reims, Vieillissement, Fragilité (VIEFRA - EA 3797), Université de Reims Champagne-Ardenne (URCA), Department of Cardiovascular Epidemiology and Population Genetics, CNIC, Eli Lilly & Company, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Sorbonne Université (SU)

    المصدر: ISSN: 2198-6576.

    مصطلحات موضوعية: Rheumatoid arthritis, Baricitinib, bDMARDs, tsDMARDs, Treatment discontinuation observational study, Effectiveness, Patient-reported outcomes, [SDV]Life Sciences [q-bio]

    العلاقة: hal-03986538; https://hal.science/hal-03986538Test; https://hal.science/hal-03986538/documentTest; https://hal.science/hal-03986538/file/2787.pdfTest

    الإتاحة: https://doi.org/10.1007/s40744-022-00500-6Test
    https://hal.science/hal-03986538Test
    https://hal.science/hal-03986538/documentTest
    https://hal.science/hal-03986538/file/2787.pdfTest

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study

    المؤلفون: Darloy, Jean, Segaud, Nicolas, Salmon, Jean-Hugues, Eschard, Jean-Paul, Goeb, Vincent, Deprez, Xavier, Guyot, Marie-Helene, Houvenagel, Eric, Lecuyer, Nicolas, Marguerie, Laurent, Gally, Samuel, Pau, David, Idier, Isabelle, Baudens, Guy, Flipo, Rene-Marc

    المساهمون: Hôpital Maison Blanche, Hôpital universitaire Robert Debré Reims (CHU Reims), Service de Rhumatologie - AMIENS (AMIENS - Rhumato), CHU Amiens-Picardie, Université catholique de Lille (UCL), Institut Calot Fondation Hopale, Roche France, Chugai Pharma France, Paris La Défense, Cabinet de Rhumatologie, Valenciennes, Hôpital Roger Salengro Lille, Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)

    المصدر: ISSN: 2198-6576.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

    العلاقة: hal-03606083; https://u-picardie.hal.science/hal-03606083Test; PUBMEDCENTRAL: PMC6393270

    الإتاحة: https://doi.org/10.1007/s40744-018-0138-yTest
    https://u-picardie.hal.science/hal-03606083Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study

    المؤلفون: Darloy, Jean, Segaud, Nicolas, Salmon, Jean-Hugues, Eschard, Jean-Paul, Goeb, Vincent, Deprez, Xavier, Guyot, Marie-Helene, Houvenagel, Eric, Lecuyer, Nicolas, Marguerie, Laurent, Gally, Samuel, Pau, David, Idier, Isabelle, Baudens, Guy, Flipo, Rene-Marc

    المساهمون: Hôpital Maison Blanche, Hôpital universitaire Robert Debré Reims, Service de Rhumatologie - AMIENS (AMIENS - Rhumato), CHU Amiens-Picardie, Université catholique de Lille (UCL), Institut Calot Fondation Hopale, Roche France, Chugai Pharma France, Paris La Défense, Cabinet de Rhumatologie, Valenciennes, Hôpital Roger Salengro Lille, Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Université de Lille

    المصدر: ISSN: 2198-6576.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

    العلاقة: hal-03606083; https://u-picardie.hal.science/hal-03606083Test; PUBMEDCENTRAL: PMC6393270

    الإتاحة: https://doi.org/10.1007/s40744-018-0138-yTest
    https://u-picardie.hal.science/hal-03606083Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study

    المؤلفون: Darloy, Jean, Segaud, Nicolas, Salmon, Jean-Hugues, Eschard, Jean-Paul, Goeb, Vincent, Deprez, Xavier, Guyot, Marie-Helene, Houvenagel, Eric, Lecuyer, Nicolas, Marguerie, Laurent, Gally, Samuel, Pau, David, Idier, Isabelle, Baudens, Guy, Flipo, Rene-Marc

    المساهمون: Hôpital Maison Blanche, Hôpital universitaire Robert Debré Reims (CHU Reims), Service de Rhumatologie - AMIENS (AMIENS - Rhumato), CHU Amiens-Picardie, Université catholique de Lille (UCL), Institut Calot Fondation Hopale, Roche France, Chugai Pharma France, Paris La Défense, Cabinet de Rhumatologie, Valenciennes, Hôpital Roger Salengro Lille, Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)

    المصدر: ISSN: 2198-6576.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

    العلاقة: hal-03606083; https://u-picardie.hal.science/hal-03606083Test; PUBMEDCENTRAL: PMC6393270

    الإتاحة: https://doi.org/10.1007/s40744-018-0138-yTest
    https://u-picardie.hal.science/hal-03606083Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study

    المؤلفون: Darloy, Jean, Segaud, Nicolas, Salmon, Jean-Hugues, Eschard, Jean-Paul, Goeb, Vincent, Deprez, Xavier, Guyot, Marie-Helene, Houvenagel, Eric, Lecuyer, Nicolas, Marguerie, Laurent, Gally, Samuel, Pau, David, Idier, Isabelle, Baudens, Guy, Flipo, Rene-Marc

    المساهمون: Hôpital Maison Blanche, Hôpital universitaire Robert Debré Reims, Service de Rhumatologie - AMIENS (AMIENS - Rhumato), CHU Amiens-Picardie, Université catholique de Lille (UCL), Institut Calot Fondation Hopale, Roche France, Chugai Pharma France, Paris La Défense, Cabinet de Rhumatologie, Valenciennes, Hôpital Roger Salengro Lille, Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Université de Lille

    المصدر: ISSN: 2198-6576.

    مصطلحات موضوعية: [SDV]Life Sciences [q-bio]

    العلاقة: hal-03606083; https://u-picardie.hal.science/hal-03606083Test; PUBMEDCENTRAL: PMC6393270

    الإتاحة: https://doi.org/10.1007/s40744-018-0138-yTest
    https://u-picardie.hal.science/hal-03606083Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث